Evidence map›Paper›PMID 35858665›Full record

ArticleThe Journal of nutritional biochemistry2022

Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice.

Suresh K Nagumalli, Rose A Willett, Aline de Conti, Volodymyr P Tryndyak, Mark I Avigan, Gonçalo Gamboa da Costa, Frederick A Beland, Ivan Rusyn, Igor P Pogribny

Open access · greenAbstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mediation analysis of the molecular phenotypes in a severe MASH-like liver injury mouse model.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  4. Article
  5. Article
  6. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Suresh K NagumalliDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA.
Rose A WillettDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA.
Aline de ContiDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA.
Volodymyr P TryndyakDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA.
Mark I AviganOffice of Pharmacovigilance and Epidemiology, FDA-Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Gonçalo Gamboa da CostaDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA.
Frederick A BelandDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA.
Ivan RusynDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, USA.
Igor P PogribnyDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA. Electronic address: igor.pogribny@fda.hhs.gov.
National Center for Toxicological Research · USCenter for Drug Evaluation and Research · USTexas A&M University · US

Funding

Chromatin regions, genes and pathways that confer susceptibility to chemical-induced DNA damageR01ES029911 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI RUSYN, IVAN, THREADGILL, DAVID W. · 2019 to 2023
$3.3M
NIEHS NIH HHS R01 ES029911
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD), one of the most common forms of chronic liver disease, is characterized by the excessive accumulation of lipid species in hepatocytes. Recent studies have indicated that in addition to the total lipid quantities, changes in lipid composition are a determining factor in hepatic lipotoxicity. Using ultra-high performance liquid chromatography coupled with electrospray tandem mass spectrometry, we analyzed the esterified fatty acid composition in 24 strains of male and female Collaborative Cross (CC) mice fed a high fat/high sucrose (HF/HS) diet for 12 weeks. Changes in lipid composition were found in all strains after the HF/HS diet, most notably characterized by increases in monounsaturated fatty acids (MUFA) and decreases in polyunsaturated fatty acids (PUFA). Similar changes in MUFA and PUFA were observed in a choline- and folate-deficient (CFD) mouse model of NAFLD, as well as in hepatocytes treated in vitro with free fatty acids. Analysis of fatty acid composition revealed that alterations were accompanied by an increase in the estimated activity of MUFA generating SCD1 enzyme and an estimated decrease in the activity of PUFA generating FADS1 and FADS2 enzymes. PUFA/MUFA ratios were inversely correlated with lipid accumulation in male and female CC mice fed the HF/HS diet and with morphological markers of hepatic injury in CFD diet-fed mouse model of NAFLD. These results demonstrate that different models of NAFLD are characterized by similar changes in the esterified fatty acid composition and that alterations in PUFA/MUFA ratios may serve as a diagnostic marker for NAFLD severity.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsCholineCollaborative Cross MiceDiet, High-FatDisease Models, AnimalFatty AcidsFatty Acids, MonounsaturatedFatty Acids, NonesterifiedFatty Acids, UnsaturatedFemaleFolic AcidLipidomicsLiverMaleMiceCholineFatty AcidsFatty Acids, MonounsaturatedFatty Acids, NonesterifiedFatty Acids, UnsaturatedFolic AcidSucroseDiet and dietary lipidsFatty acidsFatty liverLipidomicsMouse geneticsNonalcoholic fatty liver disease

Identifiers

PMID35858665
PMCPMC10103579
OpenAlexW4285736504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.